| Trial Identifier: | D6960C00001 |
| Sponsor: | AstraZeneca |
| Start Date: | August 2024 |
| Primary Completion Date: | November 2025 |
| Study Completion Date: | November 2025 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
| Country | Location |
|---|---|
| US, CA | Glendale, CA, US, 91206 |